Description

According to the Market Statsville Group (MSG), the global glutathione resin market size is expected to grow from USD 442 million in 2021 to USD 921 million by 2030, at a CAGR of 8.9% from 2022 to 2030.

Growing investments in the development of structure-based therapeutics and technological developments by both public and commercial research institutions are boosting the need for protein purification, making it the most popular application category and driving product demand. With the growing world's population, the demand for vaccinations, pharmaceutical medications, and high-quality proteins results in market expansion. Over the projection period, increased government regulations will likely limit market growth to some extent.

Global Glutathione Resin Market Definition

Due to its beneficial characteristics, glutathione is widely employed in various applications, including cosmetics and nutraceuticals. The product is one of the most commonly used skin whitening agents in the cosmetic sector. In today's market, skin whitening agents are widely available, whether intravenous, oral, or topical. Thus, glutathione demand will rise over the forecast period, particularly in the cosmetics industry.

Global Glutathione Resin Market Dynamics

Drivers: Growing pharmaceutical industry

The rapidly increasing pharmaceuticals business is driving market expansion. According to the International Federation of Pharmaceutical Manufacturers & Associations, in 2018, 59 new medicines were introduced, with over 8,000 compounds now in various stages of development around the world. In 2020, Cancer had 2,740 medications in development, Immunology had 1,535, Neurology had 1,498, and Infectious illnesses had 1,213 drugs in development. Furthermore, glutathione is a tripeptide that can be found in various pharmaceutical goods. Thus, it functions as an antioxidant, protecting cells from free radical damage and detoxifying contaminants such as pesticides, heavy metals, chemicals, and so on; it also removes poisons produced during respiration. Glutathione, on the other hand, protects against radiation and decreases the toxicity of chemotherapy medications. Furthermore, rising health and safety consciousness, a rapidly growing population, and the continuing development of bespoke affinity bioprocess resin all contribute to market growth.

Restraints: Fluctuation in raw material prices

The high prices of raw materials and the high expenses associated with resin production are limiting industry expansion. As a result, oxidized or reduced glutathione is an important raw ingredient in producing glutathione resins. This may further affect the supplier's bargaining power in the growing market era. Further, COVID leads to high prices of various raw materials, challenging for various SMEs to cope with minimal operating costs. Thus, high raw material prices and high processing costs have a substantial impact on market growth.

Opportunities: Growing adoption of glutathione in the cosmetic industry

Besides its therapeutic benefits, glutathione is becoming increasingly popular as an ingredient in cosmetic goods due to its skin-lightening properties. It helps to eliminate tan from the skin and makes it beautiful and light. It is also used as an anti-aging substance as it helps to reduce pigmentation and wrinkles. Further, the growing number of working women globally is another factor that increases the market demand. The increased glutathione applications in cosmetics give significant expansion opportunities for the market players to access wide numbers of customers from diversified industries.

COVID-19 Impact on the Global Glutathione Resin Market

The COVID-19 pandemic had a moderate influence on the market in 2020, owing to supply-demand constraints in key global economies. Furthermore, the pandemic had an impact on many end-use industries, which had an impact on overall market growth. However, due to the stability of these industries, significant end-use applications such as pharmaceuticals, biotechnology, and others are expected to drive product demand.  

Scope of the Global Glutathione Resin Market

The study categorizes the glutathione resin market based on type, product type, and application at the regional and global levels.

By Product Type (Sales, USD Million, 2017-2030)

• Oxidized Glutathione
• Reduced Glutathione

By Application (Sales, USD Million, 2017-2030)

• Protein Purification
• Immunoprecipitation (IP)
• Research
• Others

By Region (Sales, USD Million, 2017-2030)

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Italy
  • France
  • UK
  • Spain
  • Poland
  • Russia
  • The Netherlands
  • Norway
  • Czech Republic
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Indonesia
  • Malaysia
  • Thailand
  • Singapore
  • Australia & New Zealand
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Rest of South America
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Northern Africa
  • Rest of MEA

Protein purification segment is projected to account for the largest market share, by application

In 2021, the protein purification segment accounted for the largest market share in the global glutathione resin market. The rising demand for protein extraction from complicated mixtures and increased research in biotechnological and pharmaceutical industries were cited as reasons for the high share. To generate COVID-19 vaccines, companies have developed protein purification technologies. Newer methods, such as the CL7/Im7 system, allow researchers to isolate and purify protein with better yields. Purified proteins are employed in vaccine development, immunological investigations, protein-DNA interactions, and protein-protein interactions.

APAC accounts for the highest CAGR during the forecast period

Globally, APAC is estimated to hold the highest CAGR in the global glutathione resin market during the forecast period. This share is due to increased government support for domestic manufacturing, which is expected to enhance production levels and reduce reliance on imports in the Asia Pacific, providing lucrative opportunities for global manufacturers. Moreover, the growing pharmaceutical in the region will likely grow the market’s demand over the forecast period. For instance, as per India Brand Equity Foundation, the Indian pharmaceutical industry meets more than half of the global demand for numerous vaccines, around 40% of generic demand in the United States, and 25% of total medicine in the United Kingdom. The domestic pharmaceutical sector comprises 3,000 pharmaceutical businesses and 10,500 manufacturing units. India holds a significant place in the global pharmaceutical industry.

Additionally, as per China.org.cn, In 2021, the combined sales of China's pharmaceutical enterprises increased by 18.7 percent year on year, the fastest growth rate in five years. In the same year, companies in this area will earn 3.37 trillion yuan (approximately 502 billion US dollars) and research and development will also yield exponential growth. Thus, the growing pharmaceutical industry in the region’s major economies will create a lucrative growth opportunity for the glutathione resin market over the forthcoming period.

Key Market Players in the Global Glutathione Resin Market

The global glutathione resin market is highly competitive, with key industry players adopting strategies such as product development, partnerships, acquisitions, agreements, and expansion to strengthen their market positions. Most market companies focus on expanding operations across regions, augmenting their capabilities, and building strong partner relations.

Major players in the global glutathione resin market are:

• Merck KGaA
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Cytiva
• GenScript
• Takara Bio Inc.
• Mitsubishi Corporation Life Sciences Limited
• Cepham Life Sciences
• GoldBio
• Abcam plc

Recent Developments

• In July 2022, Cytiva acquired a new facility in Muskegon, Michigan, to expand its resins production activities outside of Sweden. The new chromatography resins manufacturing facility is part of a 1.5 billion USD capacity expansion project by Cytiva and Pall Corporation. Cytiva intends to develop the site into a 168,000-square-foot biomanufacturing complex comprised of various buildings.
• In April 2022, Mitsubishi Corporation Life Sciences Limited announced the grant of a patent for improving nonalcoholic fatty liver disease in patients in need of treatment, which includes the administration of a composition containing glutathione as its active ingredient.
• In January 2021, Merck announced the acquisition of AmpTec. The deal was expected to strengthen Merck’s capabilities to develop and manufacture mRNA for its customers for use in vaccines, treatments, and diagnostics applicable in Covid-19 and many other diseases.

Key Issues Addressed

• What is the market size by various segmentation of the glutathione resin by region and its respective countries?
• What are the customer buying behavior, key takeaways, and Porter's 5 forces of the glutathione resin market?
• What are the key opportunities and trends for manufacturers involved in the glutathione resin supply chain?
• What are the fundamental dynamics (drivers, restraints, opportunities, and challenges) of the market?
• What and how regulations, schemes, patents, and policies are impacting the growth of the market?
• What are the upcoming technological solutions influencing market trends? How will existing companies adapt to the new change in technology?
• The market player positioning, top winning strategies by years, company product developments, and launches will be?
• How has COVID-19 impacted the demand and sales of glutathione resins in the global market? Also, the expected BPS drop or rise count of the market and market predicted recovery period.
• Detailed analysis of the competitors and their latest launch, and what are the prominent startups introduced in the target market? Also, detailed company profiling of 25+ leading and prominent companies in the market.